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Abstract
Eukaryotic cells respond to ionizing radiation with cell cycle arrest, activation of DNA repair mechanisms, and lethality.
However, little is known about the molecular mechanisms that constitute these responses. Here we report that ionizing
 .radiation enhances epidermal growth factor EGF receptor tyrosine phosphorylation in intact cells as well as in isolated
membranes of A431 cells. Phosphoamino acid analysis revealed that ionizing radiation preferentially enhances tyrosine
 .phosphorylation, while EGF enhances the phosphorylation of all three phosphoamino acids serine, threonine and tyrosine
of the EGF receptor. In addition, radiation reduces the turnover rate of the EGF receptor, while EGF increases the rate of
the receptor turnover and down-regulation. Moreover, the confined radiation-induced phosphorylation of tyrosine residues is
inhibited by genistein, indicating that this phosphorylation of EGF receptor is due to protein tyrosine kinase activation.
These studies provide novel insights into the capacity of radiation to modulate EGF receptor phosphorylation and function.
The radiation-induced elevation in the EGF receptor tyrosine phosphorylation and the receptor’s slower rate of turnover are
discussed in terms of their possible role in cell growth and apoptosis modulation. q 1997 Elsevier Science B.V.
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1. Introduction
The molecular basis of cell sensitivity or resistance
w xto radiation is relatively unknown 1 . The contribu-
Abbreviations: EGF, epidermal growth factor; PKC, protein
kinase C; DMEM, Dulbecco’s modified Eagle’s medium; NCS,
newborn calf serum; FBS, fetal bovine serum; PBS, phosphate-
buffered saline; SDS, sodium dodecyl sulfate; PAGE, polyacryl-
w xamide gel electrophoresis; HEPES, 4- 2-hydroxyethyl -1-
piperazineethanesulfonic acid; mAb, monoclonal antibody; PAS,
protein A-Sepharose; TCA, trichloroacetic acid; EGTA, eth-
w x X Xyleneglycol bis b-aminoethyl -N,N,N ,N -tetraacetic acid; PMSF,
phenylmethylsulfonyl fluoride; mAb, monoclonal antibody
)  .Corresponding author. Tel.: q1 916 752 2988; fax: q1
 .916 752 2949.
tion of signal transduction pathways to cell resistance
or to cell sensitization to radiation is being exten-
w xsively studied in several laboratories 2–8 . In addi-
tion to causing DNA damage, ionizing radiation up-
regulates early and late response genes and perturbs
w xcell cycle 9,10 . Although the precise mechanism of
radiation-induced cell arrest has not yet been eluci-
w xdated 11 , the involvement of growth factor signal
transduction may be of fundamental importance in
w xG1 arrest and apoptosis processes 12 . It has been
shown recently in colorectal adenocarcinoma Difi
cell, which, like A431 cells, express a high number
of EGF receptors, that treatment with anti-EGF recep-
tor antibodies induces both cell cycle arrest in G1 and
w xapoptosis 13 . We have recently shown that anti-EGF
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receptor antibodies enhance radiation-induced apop-
w xtosis 14 .
EGF receptor has been detected in many kinds of
human squamous cell carcinoma and normal squa-
w xmous epithelium 15–18 , and plays an important role
w xin the proliferative processes of these cells 19 . This
receptor is a transmembrane glycoprotein of 170 000
w xkDa 20–22 . Activation of the EGF receptor tyrosine
kinase by EGF or TGFa results in a sequence of
events involved in the mitogenic signal transduction
w xpathways of cells 20 . Activation of the EGF recep-
tor occurs in the following stages: binding of EGF to
individual EGF receptors stimulates formation of
 .non-covalent dimer or oligomer structures involving
 .two or more receptors. The tyrosine kinase enzy-
matic activity of one receptor transphosphorylates
residues on the opposite member of the pair. Once
activated, the receptor initiates a series of signal
transduction events via tyrosine phosphorylation of
w xinteracting proteins of the SH2 family 20,23–28 .
Besides tyrosine phosphorylation, the in vivo EGF-
activated receptors are phosphorylated on
serinerthreonine, by which receptor functions are
attenuated. Various cellular protein kinases such as
 .protein kinase C PKC , mitogen-activated protein
kinase, p34rcdk2 kinase, and casein kinase II are
considered to be involved in this serinerthreonine
w xphosphorylation and receptor attenuation 29–32 .
We have recently demonstrated that EGF receptor
mediates resistance to radiation in A431 tumor cells
w x14 . However, it is still unclear how EGF receptor is
affected by ionizing radiation. In experiments de-
signed to explore this question, we measured receptor
phosphorylation in intact A431 cells and in mem-
brane preparations. We also studied the effects of
radiation on EGF receptor turnover. Our present find-
ings demonstrate that EGF receptor tyrosine phos-
phorylation is stimulated both when intact growing
cells or isolated membranes are exposed to radiation,
indicating that the machinery which transduces the
effects of radiation resides in the cell membrane.
Serine and threonine residues of the EGF receptor
were not phosphorylated, and the half-life of the
receptor was longer after radiation exposure. These
results provide novel insights into the effects of
radiation on the pattern of EGF receptor phosphoryla-
tion and function.
2. Materials and methods
2.1. Materials
EGF was from Collaborative Research Waltham,
. w35 x w32 x 125MA , S methionine, P orthophosphate, and I-
labeled protein A were from Du Pont–New England
Nuclear. Anti-phosphotyrosine antibody PY69 and
genistein were purchased from ICN Biochemical
 .Cleveland, OH . Anti-phosphotyrosine antibody
 .PY20 was purchased from UBI Santa Cruz . Anti-
 .EGF receptor monoclonal antibodies mAbs 528 and
LA22 were kindly provided by Dr. J. Mendelsohn
 .Memorial Sloan Kettering Cancer Center, NY and
 .Dr. J.D. Sato Alton Jones Center, Lake Placid, NY ,
respectively. Anti-EGF receptor carboxyl-terminal
peptide anti-serum RK2 was kindly provided by Dr.
J. Schlessinger New York University Medical Cen-
.ter . All the other chemicals were from Sigma unless
otherwise indicated.
2.2. Cell cultures and irradiation conditions
A431 cells were cultured in DME medium contain-
 .ing 10% fetal bovine serum FBS , Gibco Laborato-
.ries . For individual experiments, cells were seeded
into 6-well plates in appropriate medium supple-
mented with 10% FBS and switched to 1% FBS the
next day. The cells were then treated with either 5
nM EGF or with different doses of radiation, or with
both. Proliferation was assayed by trypsinizing the
cells and counting with a Coulter counter. Radiation
was delivered to cells in a Gamma-cell 40 chamber
containing two sources of 137Cs Atomic Energy of
.Canada at a dose rate of 100 cGyrmin. Cells were
exposed to single doses ranging from 200 cGy to
1000 cGy.
2.3. Western blot analysis of phosphotyrosine
A431 cells were cultured for the indicated times
after exposure to radiation in the presence or absence
of EGF, followed by removal of the culture medium
and by rinsing the cells with cold PBS. Cells were
lysed in a lysis buffer containing a mild detergent and
protease and phosphatase inhibitors 50 mM Hepes,
pH 7.5, 1% Triton X-100, 10% glycerol, 1 nM
phenylmethylsulfonyl fluoride, 10 mgrml leupeptin,
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10 mgrml aprotinin, 2 mM sodium orthovanadate,
.1.5 mM magnesium chloride, 1 mM EGTA and
incubated for 30 min at 48C. The lysates were then
mixed with concentrated SDS sample buffer to
achieve final concentrations of 62.5 nM Tris–HCl,
pH 6.8, 2% SDS, 0.5% 2-mercaptoethanol, 10%
glycerol and boiled for 5 min. Samples were analyzed
by 7% SDS–PAGE, western blotted, and nitrocellu-
lose membranes were incubated either with anti-
 .phosphotyrosine monoclonal antibody mAb PY69
 .or PY20 at concentrations of 4 mgrml , or with
anti-EGF receptor peptide polyclonal antibody RK2,
or anti-EGF receptor LA22 mAb at a concentration
.of 1 mgrml . Bound antibody was detected using
125 w xI-protein A 33 . Sample protein concentrations
were equalized before loading onto the gels. Either
whole lysate, or the immunoprecipitated with 528
.  .mAb EGF receptor see below were transferred
onto the nitrocellulose membrane, and incubated with
 .anti-phosphotyrosine antibody either PY69 or PY20 .
2.4. Cell metabolic labeling
A431 cells were plated in 10% FBS DME medium
for 2 days to reach approximately 70% confluence.
w35 xFor S methionine labeling, cells were switched to
the labeling medium 90% methionine-free DME
medium, 10% regular DME medium, 100 mCi of
w35 x .S methioninerml and 1% dialyzed FBS for 16 h.
After removing the labeling medium, the cells were
rinsed twice with fresh medium and cultures were
chased in 1% dialyzed FBS DME medium for vary-
ing periods of time in the presence of EGF or in the
absence of EGF after exposure to ionizing radiation.
w32 xFor P orthophosphate labeling, cells were grown
for 16 h in phosphate-free DME medium with the
w32 xaddition of 300 mCi of P orthophosphaterml, 4
mM glutamine, 1 mM sodium pyruvate, and 1%
dialyzed FBS. Cells were exposed to radiation, or
EGF was added during the final 30 min of labeling
w x33 . After incubation for the indicated times, cells
were rinsed with cold PBS, incubated in Triton X-100
lysis buffer, and subjected to EGF receptor immuno-
precipitation as described below.
2.5. Immunoprecipitation
A431 cells in Triton X-100 lysis buffer were incu-
bated for 30 min in an orbital shaker at 48C. To
remove insoluble material, cell lysates were cen-
trifuged at 14 000 rpm for 5 min at 48C, and super-
natants were pre-cleared by adding 50 ml of 20%
 .pansorbin Calbiochem to each sample and incubat-
ing for 1 h at 48C. Aliquots of supernatants contain-
ing equal amounts of protein were immunoprecipi-
tated for 2 h at 48C with anti-EGF receptor mAb
528rrabbit anti-mouse IgG Accurate Chemical and
. Scientific Corp. rprotein A–Sepharose Pharmacia
. w xLKB Biotechnology conjugate 33 .
2.6. In ˝itro phosphorylation
Membrane fractions were prepared and in vitro
phosphorylation assay was carried out as previously
w xdescribed 33 . Briefly, cells were collected in the
SAT buffer 0.25 M sucrose, 10 mM acetic acid, 10
.mM triethanolamine, pH 7.4 , and lysed in SEAT
 .buffer 1 mM EDTA in SAT buffer , followed by
centrifugation at 800 rpm for 5 min to pellet nuclei.
The supernatant was centrifuged at 100 000 rpm for
15 min to pellet the membrane. The resulting pellet
was resuspended in HEPES–Triton buffer 20 mM
HEPES, pH 7.4, 1% Triton X-100, 0.2 mM EDTA,
.10% glycerol and centrifuged at 100 000 rpm for 15
min. The supernatant containing the solubilized mem-
brane fraction was used. The reaction mixture for the
 .in vitro phosphorylation assay final volume: 30 ml
contained 20 mM HEPES, pH 7.4, 1 mM MnCl , 52
mg bovine serum albumin, 5 mM ATP, 10 mg mem-
brane protein. The reaction was initiated by the addi-
32  .tion of P-ATP in a total of 5 mM ATP , incubated
for 10 min, and terminated by the addition of
Laemmli’s sample buffer.
2.7. Analysis of phosphoamino acids by two-dimen-
sional electrophoresis
Two-dimensional phosphoamino acid analysis of
w32 xEGF receptors labeled metabolically with P ortho-
phosphate was performed as described previously
w x33 . Briefly, the polyacrylamide gel band containing
EGF receptors was excised and homogenized. La-
beled EGF receptors were precipitated with 15%
trichloroacetic acid and partially hydrolyzed in 100
ml of 6 N HCl at 1108C for 1 h followed by three
cycles of washing with deionized water and lyophili-
zation. The recovery of total labeled material in
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individual samples was 65–70%. The hydrolysate
was subjected to two-dimensional thin-layer elec-
trophoresis. The radioactivity associated with individ-
ual phosphoamino acids was measured by scrapping
spots from the thin-layer plate and counting in a
b-counter.
3. Results
3.1. Modulation of cell growth by radiation and by
EGF
The growth of an epithelial tumor cell line, such as
A431 cells, with elevated expression of EGF recep-
w xtor, is inhibited by EGF 33,34 . As expected, and as
shown in Fig. 1, addition of 5 nM EGF was antipro-
liferative for A431 cells. Exposure of these cells to
radiation also resulted in inhibition of the prolifera-
tive rate as compared with exponentially growing
untreated cells. The extent of radiation-induced
growth inhibition was dose-dependent and was maxi-
mized at 2000 cGy. At the same time, the viability of
the cells, as tested by Trypan blue, was not affected
by doses of radiation in the range of 100–1000 cGy.
When radiation and EGF were applied together, the
antiproliferative effects were additive, indicating two
independent effects. A simple additive response sug-
gests a lack of interaction, in that true interactive
effects would either yield synergy or antagonism.
3.2. Modulation of EGF receptor turno˝er by radia-
tion and EGF
The observation of added effects of radiation and
EGF upon A431 cell proliferation led us to search for
alterations in EGF receptor function following radia-
tion, and compare these changes to the effects of
EGF. Pulserchase experiments were carried out to
determine the effects of the natural ligand, EGF, and
radiation on EGF receptor turnover in A431 cells.
Cells which had been prelabeled with 35S methionine
were cultured in fresh medium for varying time
intervals after being supplemented with EGF or after
exposure to ionizing radiation. SDS–PAGE patterns
of immunoprecipitated EGF receptors demonstrated
that the half-life of receptors in control A431 cells
 .was approximately 13 h Fig. 2 . This fell markedly
to a half-life of less than 6 h in the presence of EGF.
On the other hand, for cells cultured after exposure to
radiation, the half-life was increased to 17 h.
3.3. Modulation of EGF receptor tyrosine phosphory-
lation by radiation and EGF
A series of experiments was carried out to deter-
mine whether radiation of A431 cells results in
 .Fig. 1. Growth inhibition of A431 cells by radiation and by EGF. A Cells were seeded at low density in DME medium supplemented
 .  .  .  .  .with 1% FBS. 24 h after seeding day 0 , cultures were untreated a ; treated with 500 cGy b ; treated with 2000 cGy c . B Cells were
 .  .  .seeded as described above. 24 h after seeding day 0 , cultures were untreated a ; treated with 250 cGy b ; supplemented with 5 nM
 .  .EGF c ; both treated with 250 cGy and supplemented with 5 nM EGF d . At the indicated times, cells were trypsinized and counted.
The results are expressed as means of triplicates with standard error bars. The initial counts were 4=104 cellsrwell.
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changes in phosphorylation of the EGF receptor.
First, the effects of radiation were examined in intact
 .cells either with whole cell lysates Fig. 3 or after
immunoprecipitation of the EGF receptor with anti-
 .EGF receptor mAb 528 Fig. 4 . Then the effects of
radiation exposure were studied on membrane prepa-
 .rations of A431 cells Fig. 5 in order to investigate
whether radiation can directly affect EGF receptor
phosphorylation under cell free conditions.
As shown in Fig. 3, A431 cell cultures were
exposed to different doses of radiation, lysates pre-
pared, and equal amounts of total protein were sub-
jected to SDS–PAGE analysis. Paired Western blots
were immunodetected either with PY69 anti-
phosphotyrosine antibody or with RK2 anti-EGF re-
ceptor antibody. Only anti-phosphotyrosine im-
munoblots show changes in the intensity of the phos-
phorylated tyrosines of the EGF receptor PY69 im-
.munoblots, Fig. 3A , while no changes are observed
in the intensity of the receptor itself RK2 im-
.munoblots, Fig. 3B . Thus the amount of EGF recep-
tor remains unchanged, while its tyrosine phosphory-
lation increases with elevated doses of radiation. As
shown in Fig. 3A and 3C, EGF receptor tyrosine
phosphorylation increased 3-fold after irradiation with
( )a dose of 500 cGy, from 1 100 cpm lane 1, control
( )to 3 500 cpm lane 3 , and 4.5-fold after irradiation
with a dose of 1 000 cGy, from 1 100 cpm lane 1,
.  .control to 4 950 cpm lane 4 . In comparison, EGF
augmented tyrosine phosphorylation 5-fold to 5 700
 .cpm lane 5 , while EGF plus 500 cGy dose of
radiation raised the receptor tyrosine phosphorylation
 .8-fold to 9 200 cpm lane 6 .
The kinetics of the effect of radiation on EGF
receptor tyrosine phosphorylation is demonstrated in
Fig. 3D. Cells were exposed to a constant dose of
500 cGy of radiation and then lysed at different time
points for western blot analysis. As shown, EGF
receptor tyrosine phosphorylation was stimulated 3-
fold in 20 min after irradiation and remained elevated
for several hours. We found that 3 h after irradiation
the receptor tyrosine phosphorylation was still about
2-fold elevated as compared to control untreated sam-
 .ples not shown .
These experiments were repeated with similar re-
sults when western blotting with anti-phospho-
 .tyrosine antibody PY69 was performed after im-
munoprecipitation of the EGF receptor with anti-EGF
 .receptor 528 mAb Fig. 4 . To further investigate the
mechanism of EGF receptor tyrosine phosphorylation
after radiation, we compared the responses to EGF
and to radiation in the presence of genistein, a known
w xspecific inhibitor of protein tyrosine kinases 35–38 .
Fig. 4B and 4C show that when A431 cells were
cultured after radiation in the presence of different
concentrations of the inhibitor, a genistein dose-de-
pendent inhibition of EGF receptor tyrosine phospho-
rylation was observed. EGF-induced tyrosine phos-
phorylation of the receptor was also partially attenu-
ated in the presence of genistein. These results pro-
vide additional evidence that radiation-induced tyro-
sine phosphorylation of EGF receptor is due to pro-
tein tyrosine kinase activation.
Finally, cell-free, in vitro, phosphorylation assay
was carried out using the membrane fractions pre-
 .pared from A431 cells Fig. 5 . As was shown previ-
 .ously with intact cells Fig. 3 A and B , when the
membrane fractions were exposed to radiation, en-
Fig. 2. Kinetics of EGF receptor turnover by radiation and by
 . 35EGF. A A431 cells were labeled with S methionine for 16 h.
The labeling medium was removed, and cultures were chased in
fresh DME medium containing 1% FBS for the indicated periods
of time in the presence of 20 nM EGF or after irradiation with
500 cGy. EGF receptors were immunoprecipitated with 528 mAb
and subjected to 7% SDS–PAGE and radio-autoradiography.
 .Representative autoradiogram of one of three experiments. B
The corresponding bands were excised and counted, and the
plotted data were used to estimate the half-lives of labeled EGF
 .receptors under the various conditions. Values mean represent
data derived from duplicate points in three experiments. The
S.E.M. of the values was 8%.
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hancement of EGF receptor tyrosine phosphorylation
was observed while the same amount of EGF recep-
tor was present. This suggests that radiation directly
affects membrane components to enhance the phos-
phorylation of EGF receptor tyrosine residues and
thus its tyrosine kinase activity.
3.4. Phosphoamino acid two-dimensional analysis of
the radiation-induced phosphorylation of the EGF
receptor
When cells are incubated with EGF, phosphoryla-
tion of EGF receptors on tyrosine residues is accom-
panied by increased phosphorylation of serine and
w xthreonine residues 39 . Therefore it was important to
investigate the effect of ionizing radiation upon the
distribution of phosphorylation between these three
phosphoamino acids. The next experiments were de-
signed to measure radiation-induced changes in the
specific amino acids phosphorylation of the EGF
 .receptor Fig. 6 . A431 cells were equilibrium-labeled
w32 xwith P orthophosphate and then treated with EGF
for 20 min at 378C, or irradiated with a dose of 500
cGy 20 min prior to being lysed. The EGF receptors
were immunoprecipitated from the lysates with 528
 .mAb and subjected to SDS–PAGE Fig. 6A . EGF
receptor bands were cut and hydrolyzed in HCl. The
amino acids were separated by two-dimensional
thin-layer electrophoresis, and 32P incorporation into
tyrosine, threonine, and serine was measured Fig.
.6B . Our results show that EGF stimulated a marked
increase in phosphorylation of tyrosine, threonine,
and serine, as expected. In contrast, ionizing radiation
selectively stimulated tyrosine phosphorylation, with
 .little increase in total phosphorylation Table 1 . Thus,
 .  .  5Fig. 3. Dose and time response of radiation-induced EGF receptor tyrosine phosphorylation. A and B A431 cell cultures 5=10
.cellsr35-mm well were exposed to different doses of radiation. Lane 1, no treatment; lanes 2, 3, 4, irradiation with doses of 250, 500
and 1 000 cGy, respectively; lane 5, treatment with 20 nM EGF; lane 6, treatment with a dose of 500 cGyq treatment with 20 nM EGF.
After 15 min at 378C cell lysates were prepared in Triton X-100 lysis buffer, subjected to 7% SDS–PAGE, and immunoblotted either
 .  .with PY69 A or with anti-EGF receptor antibody RK2 B . After autoradiography and scanning by imaging densitometer the
corresponding nitrocellulose bands were cut and counted in a b-scintillation counter. Both autoradiographies representative autoradio-
.  .  .  .gram of one of three experiments of A and B are shown. C Presentation of EGF receptor tyrosine phosphorylation dose response to
 .  .radiation demonstrated in A . D Tyrosine-specific phosphorylation of EGF receptor in A431 cells was measured after exposure to 500
 .cGy dose of radiation and incubation at 378C for the indicated time points. Values mean represent data derived from duplicate points in
 .  .three experiments. The mean range of values in C was 5% and the S.E.M. values in D was 12%.
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Fig. 4. Radiation-induced EGF receptor tyrosine phosphorylation
analyzed after immunopreciptation with anti-EGF receptor anti-
 .body A and the effect of genistein on tyrosine phosphorylation
 .  .  .B and C . A A431 cells were untreated control , treated with
 .EGF 20 nM or exposed to 500 cGy dose of radiation. After 15
min at 378C, cell lysates were prepared in Triton X-100 lysis
buffer, subjected to immunoprecipitation by the anti-EGF recep-
tor 528 mAb, analyzed on 7% SDS–PAGE, and immunoblotted
with anti-phosphotyrosine antibody PY69. Representative auto-
 .radiogram of one of three experiments. B A431 cells were
 .untreated control , treated with 20 nM EGF or exposed to 500
cGy dose of radiation as above. Increasing concentrations of
genistein inhibitor were added at the time of irradiation or EGF
exposure. Cell lysates were prepared in Triton X-100 lysis buffer
containing genistein at the same indicated concentrations. The
lysates were separated on 7% SDS–PAGE, and immunoblotted
with anti-phosphotyrosine antibody PY69. Representative auto-
 .radiogram of one of three experiments. C After autoradiography
the bands were scanned, and their relative intensities in % of
 . .control with no genistein at time 0 are presented. Values
 .mean are derived from triplicate determinations from one exper-
iment representative of three similar studies.
Fig. 5. The effect of radiation on the EGF receptor tyrosine
phosphorylation in isolated membranes. Isolated membranes were
 . treated with 20 nM EGF lane 2 or exposed to radiation 500
.cGy, lane 4 . Lane 1 is the control for EGF treatment, and lane
3 is the control for radiation exposure. After 15 min at 378C,
membranes were solubilized in Triton X-100 lysis buffer, ana-
lyzed on 7% SDS–PAGE, and immunoblotted either with PY69
 .  .A or with anti-EGF receptor antibody RK2 B . Representative
autoradiogram of one of three experiments.
Fig. 6. Phosphoamino acid two-dimensional analysis of the EGF
 .receptor. A A431 cells were labeled in phosphate-free medium
w32 xwith P orthophosphate at 378C for 16 h. 30 min prior to the
end of the labeling the following treatments were carried out:
lanes 1, no treatment; lanes 2, 20 nM EGF; lanes 3, irradiation
with a dose of 500 cGy. Subsequently, cells were lysed and the
EGF receptor was isolated by immunoprecipitation and 7%
SDS–PAGE. Representative autoradiogram of one of three exper-
 .iments is shown. B The isolated receptors were eluted from the
gel and subjected to partial acid hydrolysis. The 32P-phos-
phoamino acids were resolved by two-dimensional thin layer
electrophoresis, localized by autoradiography, and identified by
 .ninhydrin staining of carrier molecules of phosphoserine S ,
 .  .phosphothreonine T , and phosphotyrosine Y . Representative
autoradiogram of one of three experiments is shown. The amino
acids were scraped and radioactivity was assayed by scintillation
counting. The quantitative data are presented in Table 1. Values
 .mean are derived from triplicate determinations from one exper-
iment representative of three similar studies.
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Table 1
Phosphoamino acid two-dimensional analysis
 .Countsrmin %
 .  .  .Experiment Total Tyr P Thr P Ser P
 .  .  .  .1 Control 6 320 1 270 20% 1 140 18% 3 920 62%
 .  .  .  .  .2 EGF 20 nM 15 405 5 700 37% 3 851 25% 5 854 38%
 .  .  .  .  .3 Radiation 500 cGy 6 600 3 040 46% 620 9% 2 980 45%
Phosphoamino acid analysis of immunoprecipitated EGF receptors was performed as described in Fig. 6. The proportion of each
phosphoamino acid to the total of the three phosphoamino acids was determined for each group.
radiation-induced phosphorylation of the EGF recep-
tor differs from that induced by the ligand, EGF.
4. Discussion
Single and repeated radiation exposures were
shown to alter the expression of EGF receptor and
w xestrogen receptor in MCF-7 cells 40 . It has also
been shown that radiation resulted in a clear induc-
tion of EGF receptor expression in human ker-
w xatinocyes 41 , and that IGF-I receptor andror EGF
receptor function could be impaired by radiation ex-
w xposure 42 . Other receptors may also be phosphory-
lated and activated upon radiation exposure. bFGF
receptor tyrosine kinase has been reported to be
involved in the protection of bovine aortic endothelial
w xcells against the effects of ionizing radiation 2 . Two
recent publications reported that Vasoactive Intestinal
 .Peptide VIP receptors and adenylate cyclase activ-
ity in membrane isolated from pig jejunum were
w xmodified by irradiation 43 , and that induction of
inositol 1,4,5-trisphosphate receptor genes by ioniz-
ing radiation increased the level of Ins P3R type 1
w xprotein 44 . So far, all these reports have not demon-
strated any molecular data to provide mechanistic
explanation regarding radiation effects on the respec-
tive receptors.
Our experiments provide new information regard-
ing the molecular effects of ionizing radiation on the
EGF receptor. We describe the notable increase in
EGF receptor tyrosine phosphorylation and cell
growth inhibition caused by ionizing radiation. This
is not a peculiar phenomenon to A431 cells because
it was observed in other cell lines including A549,
derived from lung adenocarcinoma, and SKBR3, de-
rived from mammary carcinoma Goldkorn, unpub-
.lished .
The initial event after EGF binding is the auto-
phosphorylation of its receptor on tyrosine residues.
Studies of isolated membranes demonstrated the pres-
ence of at least five tyrosine phosphorylated residues
w xin an EGF-activated receptor 45,46 . In contrast,
studies of whole cells demonstrated a single tyrosine
phosphorylation site of the EGF receptor isolated
w xfrom EGF-treated cells 20,47 . In addition to tyro-
sine phosphorylation, serinerthreonine phosphoryla-
tion is abundant and involved in the attenuation of
w xthe EGF-activated EGF receptor 29–32 . Thus, the
low level of serinerthreonine phosphorylation in ra-
diation-activated receptor, may result in an inade-
quate diminution of receptor function.
The mechanism by which tyrosine phosphorylation
of the EGF receptor is activated by radiation is not
yet clear. EGF receptor autophosphorylation is
thought to be a trans event, involving dimerization or
oligomerization followed by tyrosine phosphorylation
w xon the opposite receptor molecule 24,27,28,39 .
Therefore, radiation could act by releasing EGF re-
ceptors from constraints which prevent dimerization
in normal physiological conditions, such as intra-
cellular inhibitors or structural elements attached to
w xintact plasma membranes 48 . Another possibility is
that radiation leads to separation of critically impor-
tant tyrosine phosphatases from their association with
the receptor kinase.
Receptor tyrosine phosphorylation induced by EGF
could markedly be increased when exposed to radia-
 .tion Fig. 3 . Therefore, the processes that contribute
to radiation-induced tyrosine phosphorylation also
have the capacity to enhance receptor activation me-
diated by its natural ligand. Moreover, our data pro-
vide strong evidence that radiation-induced EGF re-
ceptor phosphorylation results from protein tyrosine
kinase activation because the presence of genistein,
which is thought to be a competitor of ATP binding
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to tyrosine kinases, can attenuate radiation-induced
tyrosine phosphorylation. Radiation-induced EGF re-
ceptor tyrosine phosphorylation was reproduced us-
ing isolated membrane fractions from A431 cells.
This suggests that ionizing radiation may activate the
intrinsic tyrosine kinase of the EGF receptor and
phosphorylate additional tyrosine residues that are
only slightly phosphorylated under physiological con-
ditions resulting from EGF stimulation. Alternatively,
it is also possible that radiation activates an unidenti-
 .fied membrane tyrosine kinase s which is closely
associated with the EGF receptor.
Because there was no stimulation of receptor ser-
inerthreonine phosphorylation by radiation, only
minimal change in total receptor phosphorylation was
 .observed Fig. 6 and Table 1 . The low level of
serinerthreonine phosphorylation may result in an
insufficient attenuation of receptor function, such as
lack of receptor internalization. Indeed, additional
 .observations Fig. 2 suggest that receptor turnover
and down-regulation are far slower following cell
exposure to radiation than to EGF treatment.
EGF receptor may not be the only membrane
w xtarget for radiation. Our recent studies 14 have
demonstrated an immediate decrease in cellular levels
of ceramide in response to radiation. Under the same
 .conditions, the cellular 1,2-diacylglycerol DAG lev-
els decreased as well, being accompanied by the
translocation of PKCa from the membrane to the
w xcytoplasm. As also has been discussed 14 , PKC
down-modulates EGF receptor tyrosine kinase activ-
w xity via EGF receptor Thr-664 phosphorylation 39 .
Thus radiation-induced decrease in membrane PKC
may further augment EGF receptor tyrosine kinase
activity. The same may apply to radiation-induced
ceramide modulation in A431 cells. We have shown
w x49 that ceramide down-modulates EGF receptor
tyrosine kinase activity via the EGF receptor Thr-669
phosphorylation. Thus, radiation-induced decrease in
A431 ceramide contents may further promote the
EGF receptor tyrosine kinase activity. In sum, radia-
tion-induced decrease in DAG cell contents followed
by down-regulation of membranal PKC and the paral-
lel decrease in ceramide levels may just amplify the
net result of EGF receptor activation. It is interesting,
however, that these membrane-associated molecular
events cannot be generalized. It has been reported
that exposure to radiation of bovine endothelial cells
w xincreased their cellular ceramide levels 8 . It has also
been shown that radiation induced activation of PKC,
as well as bFGF receptor in these endothelial cells
w x2 .
The mechanisms by which radiation affects cell
growth are as yet unknown. In an epithelial tumor
cell line with elevated EGF receptors, EGF inhibits
growth. Even though the capacity of EGF to inhibit
the proliferation of cells expressing high levels of
w xEGF receptor is well documented 13,33 , the mecha-
nism of this inhibition remains unexplained. There
may be a quantitative relationship between EGF re-
ceptor kinase activity and growth response, and when
an optimal kinase activation is exceeded, growth
w xinhibition may result 33,34 . Cell cycle analysis
suggested that both EGF and radiation cause G1
w xarrest in cycling A431 cells 11,33 . The EGF effect
is consistent with growth inhibitory effects of
w xnanomolar EGF on A431 cells 33 , while the radia-
tion effect is suggested to be additive with EGF-in-
duced G1 arrest, consistent with the additive in-
hibitory effects of radiation and EGF treatment. These
results pose an additional interesting question whether
EGF receptor and its ligand could also contribute to
programmed cell death.
w xWe have recently 14 measured the initial apop-
totic response of A431 cells to EGF, to radiation and
 .to mAb LA22 to EGF receptor. EGF alone slightly
inhibited apoptosis, while LA22 slightly enhanced
apoptosis in these cells. Moreover, radiation alone
induced very low levels of apoptosis, but LA22
highly enhanced radiation-induced apoptosis by pre-
venting the EGF receptor activation. We thus found
that radiation-induced apoptosis could be enhanced
by LA22. EGF, which activates the tyrosine kinase
activity of EGF receptor, could delay mAb LA22-in-
duced apoptosis. In sum, only combined treatment of
mAbs to EGF receptor which inhibit EGF receptor
.tyrosine kinase activity together with radiation en-
w xhanced apoptosis. These results 14 demonstrated
that in cancer cells such as A431, which overexpress
the EGF receptor, radiation activates predominantly
the EGF receptor to induce resistance to apoptosis,
while anti-EGF receptor antibodies were shown to
sensitize the cells to radiation by inducing apoptosis.
The present studies provide some mechanistic in-
sights into the molecular effects of radiation on EGF
receptor. As shown, the extent of tyrosine versus
( )T. Goldkorn et al.rBiochimica et Biophysica Acta 1358 1997 289–299298
serinerthreonine phosphorylation in EGF receptor
differs when cells are treated with EGF or with
ionizing radiation, although both are growth-inhibi-
tory stimuli. In contrast to EGF, ionizing radiation
fails to modulate threoninerserine phosphorylation
and to decrease the half-life of the receptor. As
illustrated, radiation causes tyrosine phosphorylation
without the accompanying effects of threoninerserine
phosphorylation. It may thus create an aberrantly
activated receptor which fails to be turned over in a
regular manner. Such a receptor may antagonize
apoptosis while still inhibiting cell growth.
The capacity of radiation to modify cell prolifera-
tion may partially reside in its ability to act as a
direct biomodulator of the phosphorylation and func-
tion of the EGF receptor. This does not rule out a role
for radiation as a biomodulator of other mechanisms
involved in cellular growth. The finding that EGF
receptor phosphorylation is affected by ionizing radi-
ation and the distinction between the action of EGF
and radiation on the EGF receptor pattern of phos-
phorylation may supply important clues toward the
understanding of the mechanisms through which radi-
ation interacts with regulatory signal transduction
pathways.
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